New Senate Bill Proposes Supply Chain Requirements for Drug Firms, Mandatory Recall Authority for FDA
Aug 11th, 2010
Please Log in to print the full article
A bill introduced in the Senate in early August would amend the Food, Drug and Cosmetic (FD&C) Act to provide FDA with new monetary penalty and recall tools and require drug firms to audit and...
You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.